{"id":"placebo-matched-to-suz","safety":{"commonSideEffects":[]},"_chembl":{"chemblId":"CHEMBL6068498","moleculeType":"Vaccine component"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Placebo serves as a control comparator in clinical trials to establish the efficacy of the active investigational drug (SUZ) by comparison. It contains no active pharmaceutical ingredient and produces therapeutic effects only through psychological mechanisms such as expectation and conditioning.","oneSentence":"Placebo is an inert substance with no active pharmacological mechanism.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:27:49.071Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[]},"trialDetails":[{"nctId":"NCT07231419","phase":"PHASE3","title":"Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy","status":"RECRUITING","sponsor":"Vertex Pharmaceuticals Incorporated","startDate":"2025-11-21","conditions":"Diabetic Peripheral Neuropathic Pain","enrollment":734},{"nctId":"NCT06628908","phase":"PHASE3","title":"Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy","status":"RECRUITING","sponsor":"Vertex Pharmaceuticals Incorporated","startDate":"2024-10-01","conditions":"Diabetic Peripheral Neuropathic Pain","enrollment":1100},{"nctId":"NCT07145346","phase":"PHASE4","title":"Suzetrigine for Acute Pain Control in Patients With Multiple Rib Fractures","status":"ENROLLING_BY_INVITATION","sponsor":"University of California, Irvine","startDate":"2025-11-13","conditions":"Rib Fractures","enrollment":80},{"nctId":"NCT05553366","phase":"PHASE3","title":"Evaluation of Efficacy and Safety of VX-548 for Acute Pain After a Bunionectomy","status":"COMPLETED","sponsor":"Vertex Pharmaceuticals Incorporated","startDate":"2022-10-03","conditions":"Acute Pain","enrollment":1075},{"nctId":"NCT05558410","phase":"PHASE3","title":"Evaluation of Efficacy and Safety of Suzetrigine for Acute Pain After an Abdominoplasty","status":"COMPLETED","sponsor":"Vertex Pharmaceuticals Incorporated","startDate":"2022-10-10","conditions":"Acute Pain","enrollment":1118},{"nctId":"NCT05660538","phase":"PHASE2","title":"Evaluation of Efficacy and Safety of VX-548 for Painful Diabetic Peripheral Neuropathy (DPN)","status":"COMPLETED","sponsor":"Vertex Pharmaceuticals Incorporated","startDate":"2022-12-20","conditions":"Diabetic Peripheral Neuropathy","enrollment":194}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Placebo (matched to SUZ)","genericName":"Placebo (matched to SUZ)","companyName":"Vertex Pharmaceuticals Incorporated","companyId":"vertex-pharmaceuticals-incorporated","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}